Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Fufeng Group Limited Regulatory Filings 2021

Dec 28, 2021

49286_rns_2021-12-28_98e2bdc3-635b-4582-bff9-471e0c93406f.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [74 x 57] intentionally omitted <==

Fufeng Group Limited 阜豐集團有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 546)

INSIDE INFORMATION ANNOUNCEMENT

This announcement is made by Fufeng Group Limited (“ Company ”, and together with its subsidiaries, the “ Group ”) pursuant to the Inside Information Provisions (“ Inside Information Provisions ”) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) and Rule 13.09(2) of the Rules Governing the Listing of Securities (the “ Listing Rules ”) on The Stock Exchange of Hong Kong Limited.

The Company has noted that Uyghur Forced Labor Prevention Act (the “ Act ”) has been signed by the President of the United States of America (the “ United States ”) on 23 December 2021 (United States time). Such Act would, among others, create a rebuttable presumption which shall take effect on the date that is 180 days after the date of enactment of the Act that all goods from Xinjiang were made with forced labour and therefore prohibited for import into the United States.

The board of directors of the Company (the “ Board ”) would like to inform that the Company has a wholly-owned subsidiary, Xinjiang Fufeng Biotechnologies Co. Ltd (“ Xinjiang Fufeng ”), based in Xinjiang and is mainly used for the production and sale of xanthan gum and high end amino acid products. For the six months ended 30 June 2021, the unaudited sales amount of export from Xinjiang Fufeng to the United States is approximately RMB136,000,000, accounting for less than 1.5% of the total revenue of the Group in the same period.

The Board considers the impact of the Act on the Group’s overall business and financial performance to be limited. The Group intends to continue the sale of products from Xinjiang Fufeng to the United States and will consider to apply for an exemption license in accordance with the local regulations.

The Company will make further announcement(s) as and when necessary in compliance with the Listing Rules in the event of any material developments of the above matter.

– 1 –

Shareholders and prospective investors are advised to exercise caution when dealing in the shares and other securities of the Company.

By Order of the Board Fufeng Group Limited Li Xuechun Chairman

Hong Kong, 28 December 2021

As at the date of this announcement, the executive directors of the Company are Mr. Li Xuechun, Mr. Li Deheng and Mr. Li Guangyu and the independent non-executive directors of the Company are Mr. Lau Chung Wai, Mr. Xu Zheng Hong and Mr. Zhang You Ming.

– 2 –